← Back to Screener
20/20 Biolabs, Inc. Common Stock (AIDX)
Price$0.80
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (4W)-40.49%
VGM Score20.92
All Metrics
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-106.96%
10-Day Avg Trading Volume1.12M
3-Month Avg Trading Volume0.35M
52-Week High$50.00
13-Week Price Return-73.97%
3-Month Return Std Dev101.33%
Year-to-Date Return-96.35%
5-Day Price Return0.29%
Month-to-Date Return0.29%
Price vs S&P 500 (13W)-84.47%
Beta3.55x
52-Week Low$0.83
mGradeD
vgmGradeD
Show chart for
Industry Peers — Testing Laboratories(3)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
AIDX20/20 Biolabs, Inc. Common Stock | — | — | D | $0.80 |
| ULSUL Solutions Inc. | F | C | B | $96.81 |
| NEONeoGenomics, Inc. | D | B | B | $10.90 |
| BNBXBNB Plus Corp. Common Stock | B | D | F | $0.54 |
About
20/20 Biolabs is a commercial-stage diagnostics company developing ML-powered laboratory tests for early disease detection. The company offers two main products: OneTest for Cancer, a multi-cancer early detection blood test, and OneTest for Longevity, which measures inflammatory biomarkers. Both tests leverage real-world data to enhance diagnostic accuracy and clinical utility.